92.21USD+0.96%Mkt Cap: 53.09B $P/E: 49.84Today
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap53.09B $
Enterprise Value49.62B $
Revenue (TTM)6.30B $
Gross Profit4.73B $
Net Income (TTM)1.07B $
Revenue/Share10.81 USD
Last Price92.21 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS28176E1082
Valuation
P/E (Trailing)49.84
P/E (Forward)27.12
PEG2.29
EV/EBITDA26.07
EV/Revenue7.87
P/S8.34
P/B5.10
EPS (TTM)1.81
EPS (Forward)3.37
52W Range
72.3083% of range96.29
52W High96.29 USD
52W Low72.30 USD
Profitability
Gross Margin78.01%
Oper. Margin31.22%
EBITDA Margin30.20%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth16.70%
Earnings Growth8.20%
Cash Flow & Leverage
Operating CF1.60B $
CapEx (TTM)260.20M $
FCF Margin14.31%
FCF Yield1.70%
Net Debt-2.97B $
Net Debt/EBITDA-1.56
Balance Sheet
Debt/Equity0.07
Current Ratio4.42
Quick Ratio3.30
Book Value/Sh17.90 USD
Cash/Share6.376 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)97.31 USD
Upside (mean)+5.5%
Target Range84.00 USD – 110.00 USD
$84.00+5.5% to mean$110.00
# Analysts26
Ownership
Shares Out.575.80M
Float573.99M
Insiders0.18%
Institutions94.20%
Short Interest
Short Ratio2.3d
Short % Float2.33%
Short % Out.2.05%
Shares Short11.80M
Short (prev mo.)11.39M
Technical
SMA 5086.15 (+7.0%)
SMA 20082.83 (+11.3%)
Beta0.85
S&P 52W Chg20.11%
Avg Vol (30d)3.33M
Avg Vol (10d)5.11M
Technical Indicators
RSI (14)58.2
MACD2.0622
MACD Signal1.9838
MACD Hist.+0.0783
BB Upper96.34 USD
BB Middle89.90 USD
BB Lower83.45 USD
BB Width14.34%
ATR (14)2.356 USD
Vol Ratio (20d)0.76x